Correlation Between Candel Therapeutics and OKYO Pharma
Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and OKYO Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and OKYO Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Candel Therapeutics and OKYO Pharma Ltd, you can compare the effects of market volatilities on Candel Therapeutics and OKYO Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of OKYO Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and OKYO Pharma.
Diversification Opportunities for Candel Therapeutics and OKYO Pharma
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Candel and OKYO is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and OKYO Pharma Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OKYO Pharma and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with OKYO Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OKYO Pharma has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and OKYO Pharma go up and down completely randomly.
Pair Corralation between Candel Therapeutics and OKYO Pharma
Given the investment horizon of 90 days Candel Therapeutics is expected to under-perform the OKYO Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Candel Therapeutics is 1.32 times less risky than OKYO Pharma. The stock trades about -0.06 of its potential returns per unit of risk. The OKYO Pharma Ltd is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 127.00 in OKYO Pharma Ltd on September 5, 2024 and sell it today you would lose (25.90) from holding OKYO Pharma Ltd or give up 20.39% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Candel Therapeutics vs. OKYO Pharma Ltd
Performance |
Timeline |
Candel Therapeutics |
OKYO Pharma |
Candel Therapeutics and OKYO Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Candel Therapeutics and OKYO Pharma
The main advantage of trading using opposite Candel Therapeutics and OKYO Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, OKYO Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OKYO Pharma will offset losses from the drop in OKYO Pharma's long position.Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
OKYO Pharma vs. Candel Therapeutics | OKYO Pharma vs. Anebulo Pharmaceuticals | OKYO Pharma vs. Cingulate Warrants | OKYO Pharma vs. Unicycive Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |